Navitor Japan Study

Exclusion Criteria

• •2. Life expectancy \< 12 months from the time of informed consent due to non-cardiac co-morbid conditions.
• •3. In the judgment of the Investigator, patient presents with a medical, social, or psychological condition that could limit the ability or willingness to participate in the study, comply with study required testing and/or follow-up visits or that could impact scientific integrity of the study.
• •4. Known contraindication for computed tomography (CT) or sensitivity to contrast media, which cannot be adequately premedicated.
• •5. Inability to tolerate antiplatelet/anticoagulation therapy or nitinol alloy (nickel and titanium), which cannot be adequately premedicated.
• •6. Currently participating in an investigational drug or device study that may confound the results of this study.
• •7. Anatomy that makes insertion and endovascular access to the aortic valve difficult and/or impossible.